Fund profile · Compiled from public sources

EFung Capital

Shenzhen, China · Series A → Growth

Their stated focus (public profile)

EFung Capital is one of China's earliest specialized biopharmaceutical investment institutions, focused on global biomedical VC/PE investing. The investment team is composed of PhD professionals from top domestic and international universities. The firm aims to drive the commercialization of biotechnology through capital, with a philosophy centered on entrepreneurs and value creators.

Stages: Series A → Growth

Sectors: Life sciences, Medtech, Healthtech

On file: 14 companies on record

Website: efungcapital.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →